High-Yield Hitters: Cutaneous Manifestations of Systemic Disease
Do you feel comfortable recognizing retiform purpura and initiating the work up to identify the underlying etiology? What can cause “cellulitis” on the breast that does not get better with antibiotics? What are the most common drug culprits triggering eczematous eruptions in the elderly and stubborn psoriasis? What medication is associated with vulvovaginal pyoderma gangrenosum? If these cas …
Do you feel comfortable recognizing retiform purpura and initiating the work up to identify the underlying etiology? What can cause “cellulitis” on the breast that does not get better with antibiotics? What are the most common drug culprits triggering eczematous eruptions in the elderly and stubborn psoriasis? What medication is associated with vulvovaginal pyoderma gangrenosum? If these cas … Continue reading "High-Yield Hitters: Cutaneous Manifestations of Systemic Disease"
What is Hyperhidrosis (HH)?
Primary HH is defined as excessive, bilateral, and generally symmetrical sweating at abnormal levels unprompted by activity or environment.
Hyperhidrosis is characterized by abnormal sweating beyond what is needed for thermoregulation. It is not a normal physiologic response. Nearly 15 million people in the United States suffer from hyperhidrosis and half of thos … 
The March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, … 
Treatment of malignancy with anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors can cause mucocutaneous side effects resulting from T cell activation. Due to their recent development, the full side effect profile remains to be fully elucidated, however dermatologic adverse events are most common. The main oral toxicities of these immune checkpoint inhibitors include: xerostomia, dysg … 
Dr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020.
How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us … 